Ekkehard Schütz

2023

In 2023, Ekkehard Schütz earned a total compensation of $575.2K as Chief Science Officer at Oncocyte Corp.

Compensation breakdown

Bonus$132,700
Option Awards$165,892
Salary$242,028
Other$34,547
Total$575,167

Schütz received $242K in salary, accounting for 42% of the total pay in 2023.

Schütz also received $132.7K in bonus, $165.9K in option awards and $34.5K in other compensation.

Rankings

In 2023, Ekkehard Schütz's compensation ranked 1,842nd out of 2,918 executives tracked by ExecPay. In other words, Schütz earned more than 36.9% of executives.

ClassificationRankingPercentile
All
1,842
out of 2,918
37th
Division
Manufacturing
1,064
out of 1,608
34th
Major group
Chemicals And Allied Products
663
out of 901
26th
Industry group
Drugs
646
out of 864
25th
Industry
In Vitro and In Vivo Diagnostic Substances
6
out of 14
57th
Source: SEC filing on April 29, 2024.

Schütz's colleagues

We found three more compensation records of executives who worked with Ekkehard Schütz at Oncocyte Corp in 2023.

2023

Joshua Riggs

Oncocyte Corp

Chief Executive Officer

2023

Anish John

Oncocyte Corp

Chief Financial Officer

2023

James Liu

Oncocyte Corp

Controller and Principal Accounting Officer

News

You may also like